the Effect of Tracleer on Tourniquet-associated Hypertension
Effect of Endothelin Receptor Blocker Tracleer on Toruniquet-associated Hypertension During Total Knee Arthroplasty
Sponsor: Xuzhou Medical University
Listed as NCT03229694, this PHASE4 trial focuses on Bosentan and Hypertension and remains ongoing. Sponsored by Xuzhou Medical University, it has been updated 6 times since 2017, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Aug 2019 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Not Yet Recruiting → Unknown Status
-
Jun 2018 — Aug 2019 [monthly]
Not Yet Recruiting PHASE4
▶ Show 1 earlier version
-
Aug 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Xuzhou Medical University
For direct contact, visit the study record on ClinicalTrials.gov .